Table 2.
Primer | Sequence | |
---|---|---|
Human | ||
Farnesoid X Receptor (FXR) | Forward Reverse |
CCGTGAATGAAGACAGTGAAGGTCG ACCCTTTCAGCAAAGCCAATCTGGTC |
Porcine | ||
Fibroblast growth factor 19 (FGF19) | Forward Reverse |
ACACCATCTGCCCGTCTCT CCCCTGCCTTTGTACAGC |
FXR | Forward Reverse |
ACATTCCTCATTCTGGGGCTTT TTTCGGGGTCTTACTCCTTACA |
FGF19 Receptor: FGFR4 | Forward Reverse |
CGCTCGCGGCCACGCCGCCGT TGCCGCCGCACCGGCGCTCGC |
Cholesterol 7 α-hydroxylase (CyP7A1) | Forward Reverse |
AGGGTGACGCCTTGAATTT GGGTCTCAGGACAAGTTGGA |
Small heterodimer partner (SHP) | Forward Reverse |
AGTGCTGCCTGGAGTCCTTA CCTTTCAGGTAGGCGTATTCC |
Constitutive androstane receptor (CAR) | Forward Reverse |
CCGCCATATGGGCACTATGT GCGAAATGCATGAGCAGAGA |
Organic solute steroid transporter α (OSTα) | Forward Reverse |
CCTGTTTCTCATCCCTGACG AGCAGCGCTCTCCTCAGA |
Multidrug-associated protein (MRP) | Forward Reverse |
TCTTGGTGACACACAGCATTC TTCCCACAACCACAATCTCA |
Peroxisome proliferator-activated receptor (PPAR) | Forward Reverse |
CAGCCTCCAGCCCCTCGTC GCGGTCTCGGCATCTTCTAGG |
β-Actin | Forward Reverse |
5′-GGACCTGACCGACTACCTCA 5′-GCGACGTAGCAG AGCTTCTC |